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Abstract We have attempted to elucidate the mechanism of
apoptotic cell death induced by hypoxia (very low oxygen
conditions) in neuronal cells. Human neuroblastoma SK-N-MC
cells under hypoxic conditions resulted in apoptosis in a time-
dependent manner estimated by DNA fragmentation assay and
nuclear morphology stained with fluorescent chromatin dye.
Pretreatment with Z-Asp-CH2-DCB, a caspase inhibitor,
suppressed the DNA ladder in response to hypoxia in a
concentration-dependent manner. An increase in caspase-3-like
protease (DEVDase) activity was observed during apoptosis, but
no caspase-1 activity (YVADase) was detected. To confirm the
involvement of caspase-3 during apoptosis, Western blot analysis
was performed using anti-caspase-3 antibody. The 20- and 17-
kDa proteins, corresponding to the active products of caspase-3,
were generated in hypoxia-challenged lysates in which processing
of the full length form of caspase-3 was evident. With a time
course similar to this caspase-3 activation, hypoxic stress caused
the cleavage of PARP, yielding an 85-kDa fragment typical of
caspase activity. In addition, caspase-2 was also activated by
hypoxia, and the stress elicited the release of cytochrome c into
the cytosol during apoptosis. These results suggest that caspase
activation and cytochrome c release play roles in hypoxia-
induced neuronal apoptosis.
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1. Introduction
There are two distinct essential morphological manifesta-
tions of cell death; one is apoptosis and another is necrosis
[1]. Apoptosis is characterized by the condensation of chro-
matin and cytoplasm, membrane blebbing and apoptotic
bodies, whereas necrosis features plasma membrane disrup-
tion and mitochondrial swelling associated with formation
of large vacuoles. It is still not fully understood whether or
not neuronal death in vivo is apoptosis or necrosis. Following
transient ischemia in gerbils and rats, however, it has been
demonstrated that at least some cell death is attributed to
apoptosis, determined by in situ nick-end labeling of biotinyl-
ated dUTP by terminal deoxytransferase (TUNEL staining)
[2,3].
Brain ischemia brings about hypoxic (or near-anoxic) and
hypoglycemic insults. Hypoxia is one of the major patholog-
ical factors inducing neuronal injury. In vivo, hypoxic stress
leads to increased utilization of endogenous substrates, ATP
depletion, membrane depolarization, excessive release and re-
duced re-uptake of glutamate or aspartate, a loss of neuronal
ion homeostasis and ¢nally, irreversible brain damage [4^6].
On the other hand, hypoxia itself causes apoptotic cell death
in human ¢broblast cell line GM701, human lymphoid cell
line SKW6.4, murine pro-B cell line BAF3, rat hepatoma
cell line 7316A, and rat pheochromocytoma cell line PC12
[7,8] in vitro. Furthermore, it has been reported that apoptotic
cell death induced by ischemia or low level of oxygen is pre-
vented by Bcl-2 and Bcl-XL [9^13]. Caspase inhibitors have
been shown to signi¢cantly block cell death, suggesting that
some caspases are involved in hypoxia-induced apoptosis in a
Bcl-2-dependent manner [14]. Indeed, Shimizu et al. [15] re-
ported that activation of both caspase-1-like and caspase-3-
like proteases (YVADase and DEVDase) was observed
during hypoxic conditions in rat primary hepatocytes. More
recently, Yoshimura et al. [16] demonstrated that ceramide
formation during hypoxia is linked to caspase-3-like protease
(DEVDase) activation in PC12 cells. However, the precise
mechanism of hypoxia-induced apoptosis is still unclear.
In the present study, we attempted to clarify the mechanism
of hypoxia-induced apoptosis using human neuroblastoma
cell line SK-N-MC. Exposure to hypoxia elicited apoptotic
cell death in a time-dependent manner in SK-N-MC cells.
The cell death induced by hypoxia was blocked by treatment
with caspase inhibitor. Furthermore, we report that hypoxia
stimulated caspase-3 activity, but not caspase-1. This may be
linked to apoptosis accompanied by the release of cytochrome
c from mitochondria.
2. Materials and methods
2.1. Cell culture
Human SK-N-MC cells were maintained in Dulbecco’s modi¢ed
Eagle’s medium supplemented with 10% (v/v) heat-inactivated fetal
calf serum at 37‡C in humidi¢ed 5% CO2/95% air.
2.2. Exposure to hypoxic environment
When SK-N-MC cells achieved 80% con£uence, the cells were cul-
tured in a mixture of 5% CO2 and the balance N2 in a humidi¢ed
37‡C incubator (ANX-1, Hirasawa, Tokyo, Japan) that was contained
in a sealed, anaerobic glove cabinet ¢tted with a catalyst to scavenge
free oxygen. Oxygen tension in the chamber and in the medium were
measured using a portable trace oxygen analyzer (Teledyne, USA)
and a blood gas analyzer (ABL-2, Radiometer, Sweden), respectively.
FEBS 21117 17-11-98 Cyaan Magenta Geel Zwart
0014-5793/98/$19.00 ß 1998 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 9 8 ) 0 1 3 6 3 - 5
*Corresponding author. Fax: (81) (11) 706-4987.
E-mail: nomura@pharm.hokudai.ac.jp
Abbreviations : Z-Asp-CH2-DCB, benzyloxycarbonyl-Asp-
CH2OC(O)-2,6-dichlorobenzene ; CPP32, cysteine protease p32;
DEVD-MCA, N-acetyl-Asp-Glu-Val-Asp-4-methylcoumaryl-7-amide;
YVAD-MCA, N-acetyl-Tyr-Val-Ala-Asp-4-methylcoumaryl-7-amide;
AMC, 7-amino-4-methylcoumarin; ICE, interleukin-1L-converting
enzyme; ICH-1, ICE and CED-3 homolog 1; PARP, poly(ADP-
ribose) polymerase; PBS, phosphate-buffered saline; PMSF, phenyl-
methylsulfonyl fluoride
FEBS 21117FEBS Letters 439 (1998) 168^172
The oxygen concentration in the chamber remained below 10 p.p.m.
throughout the incubation period. On the other hand, oxygen tension
in the culture medium at 15 min, 30 min, 1 h, 6 h, and 48 h after
transfer into the hypoxic chamber fell to 4.3, 3.0, 2.2, 2.0, and
2.0 þ 0.2%, respectively.
2.3. DNA fragmentation
The cells were washed with PBS and lysed (lysis bu¡er: 10 mM
Tris-HCl (pH 7.4), 5 mM EDTA, 0.5% Triton X-100) for 20 min at
4‡C. The samples were centrifuged at 27 000Ug for 15 min at 4‡C.
The DNA in the supernatant was extracted in three steps with equal
volumes of phenol, phenol/chloroform (1:1, v/v), and then chloro-
form. Then the DNA was precipitated with 0.1 volume of 3 M sodium
acetate (pH 5.2) and 2 volumes of ethanol. The DNA was resus-
pended in TE bu¡er (10 mM Tris-HCl (pH 8.0), 1 mM EDTA) and
treated with 40 Wg/ml RNase A for 1 h at 37‡C. The DNA concen-
tration was determined by absorbance at 260 nm. Twenty mg of DNA
from the samples was subjected to agarose gel electrophoresis on a
1.5% gel in TAE bu¡er (40 mM Tris-HCl (pH 8.5), 2 mM EDTA).
Then the gel was stained with 0.5 mg/ml ethidium bromide for 15 min,
and the fragmented DNA was visualized under UV light and photo-
graphed [17].
2.4. Assessment of nuclear morphology
Chromosomal condensation and DNA fragmentation were assessed
using the chromatin dye Hoechst 33258 as described [18]. Cells were
¢xed for 30 min in PBS containing 1% glutaraldehyde. After ¢xation
at room temperature, the cells were washed twice with PBS and then
exposed to 5 Wg/ml Hoechst 33258 in PBS for 30 min at room temper-
ature. After washing, all samples were mounted with glycerol/PBS
(1:1, v/v) and observed using a non-confocal £uorescence microscope.
2.5. Assay for caspase activity
Cells in 60-mm plates were cultured in the low oxygen chamber for
the indicated periods. At the appropriate time, the medium was aspi-
rated and the cells were washed with PBS and 50 Wl of lysis bu¡er
(50 mM Tris-HCl (pH 7.4), 1 mM EDTA, 10 mM EGTA, and 10 mM
digitonin) was added. The cells were incubated for 10 min at 37‡C.
After incubation, the supernatant was centrifuged at 15 000 rpm for
10 min. Next, the separated lysate (50 Wg protein) was incubated at
37‡C with 50 WM Ac-DEVD-MCA for 30 min or Ac-YVAD-MCA
for 60 min. The amounts of 7-amino-4-methylcoumarin (AMC) re-
leased were measured using a spectro£uorometer (Hitachi F-2000 Flu-
orescence Spectrophotometer) with excitation at 380 nm and emission
at 460 nm. One unit was de¢ned as the amount of enzyme required to
release 1 pmol of AMC per min at 37‡C.
2.6. Western blot analysis
The cells (5U105) were washed twice with ice-cold PBS and then
500 Wl of bu¡er A (50 mM Tris (pH 7.4), 1 mM EDTA, 1 mM
EGTA, 250 mM sucrose, 2 mg/ml leupeptin, 1 mM PMSF, and
1 mg/ml pepstatin) was added. The cells were disrupted with 10 strokes
of a Dounce homogenizer. The homogenates were separated as cyto-
sol and membrane fractions by ultracentrifugation. Then, the lysates
and membranes were boiled for 5 min with SDS sample bu¡er. Equal
amounts of each sample (20 Wg) were subjected to 12% SDS-PAGE at
100 V for 1 h at 4‡C, followed by transfer to a nitrocellulose ¢lter.
The ¢lters were then blocked with TBST (10 mM Tris-HCl (pH 7.5),
100 mM NaCl, 0.1% Tween 20) containing 5% non-fat milk for 1 h at
room temperature. Human anti-Ich-1 (caspase-2, Santa Cruz), anti-
caspase-3 (PharMingen), and anti-PARP (Clontech) were used as pri-
mary antibodies, and horseradish peroxidase-labeled goat or mouse Ig
was used as a secondary antibody. The antibody-reactive bands were
revealed by chemiluminescence (ECL Western detection kit). Cyto-
chrome c protein was detected by Western blot analysis as described
[19]. Equal amounts of protein (10 Wg) were subjected to Western blot
analysis using mouse monoclonal anti-cytochrome c antibody
(7H8.2C12, PharMingen).
3. Results
3.1. Hypoxia induced apoptotic cell death in SK-N-MC cells
To address the ability of hypoxia to induce cell death, we
¢rst investigated the e¡ect of hypoxia on cell viability using an
LDH leakage assay. Approximately 10% of the total LDH
activity spontaneously leaked to the culture medium in con-
trol cells (Fig. 1A). A small loss of viability was observed
within 18 h of a hypoxia challenge. Loss of viability occurred
following treatment with hypoxia in a time-dependent man-
ner. At 24 h the leakage increased to 30% compared to that of
control cultures, and by 48 h LDH leakage increased to 70%.
We employed two methods to investigate whether the loss of
viability caused by hypoxia correlates with a biochemical fea-
ture that discriminates between apoptosis and necrosis. In
order to characterize apoptosis, internucleosomal DNA frag-
mentation and nuclear morphology using chromatin dye were
examined.
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Fig. 1. Exposure to hypoxia resulted in apoptosis in SK-N-MC cells. A: Time course of LDH leakage during hypoxia. The cells were exposed
to hypoxia for the indicated periods (0^48 h) and then LDH activity was measured as described in Section 2. Data are means þ S.E.M. of trip-
licate reactions run in parallel. B: Time course of DNA fragmentation in response to hypoxia and e¡ect of Z-Asp-CH2-DCB on hypoxia-
induced DNA fragmentation. SK-N-MC cells were treated or not treated with 100 mM of Z-Asp-CH2-DCB (Z-Asp). Then cells were incubated
in a hypoxic environment for various periods (0^48 h) and subjected to DNA fragmentation assay as described in Section 2. C: Hypoxia-
induced nuclear DNA condensation and fragmentation in SK-N-MC cells. Fluorescence micrographs were taken of cells stained with Hoechst
33258. Cultures incubated with normoxia (a), hypoxia (b) for 36 h are shown. Very few apoptotic nuclei were observed in control SK-N-MC
cells (a). Exposure to hypoxia for 36 h induced nuclear DNA condensation and fragmentation (b). In a and b, bar = 50 mm.
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DNA from hypoxia-treated cells was examined for oligonu-
cleosomal fragmentation by agarose gel electrophoresis. No
internucleosomal DNA fragmentation was observed in con-
trol cultures. Low molecular weight DNA extracted from SK-
N-MC cells challenged with hypoxia produced an oligosomal
DNA ladder in a time-dependent manner on agarose gels
stained with ethidium bromide in parallel with the appearance
of signi¢cant LDH leakage (Fig. 1B). Further, nuclear stain-
ing with Hoechst 33258 chromatin dye was utilized to con¢rm
whether the loss of viability was attributed to apoptosis. Min-
imal nuclear condensation was observed in non-treated cells
(Fig. 1C). In cells incubated with hypoxia for 36 h, conden-
sation and fragmentation of the chromatin, and shrinkage and
fragmentation of the nuclei as apoptotic bodies were evident
(Fig. 1C).
3.2. Hypoxia induced apoptotic cell death via caspase
activation
To determine whether caspases contribute to hypoxia-
induced apoptosis, the presence of a DNA ladder in SK-N-
MC cells following treatment with hypoxia was examined in
the presence or absence of Z-Asp-CH2-DCB, a cell-permeable
non-speci¢c caspase inhibitor. Formation of a DNA ladder in
cells 24 and 36 h after hypoxia challenge was suppressed by
simultaneous treatment with Z-Asp-CH2-DCB (Fig. 1B).
Having established a role for caspases in cell death induced
by hypoxia, we analyzed the process of caspase activation in
this system. Detergent extracts prepared from cells at various
stages after treatment with hypoxia were tested for cleaving
action on two £uorogenic peptide substrates (Ac-DEVD-
MCA and Ac-YVAD-MCA). Ac-DEVD-MCA is a £uorogen-
ic, tetrapeptide substrate that is cleaved by caspase-3 and -7,
but may also be cleaved by other caspases. The second pep-
tide, Ac-YVAD-MCA, is cleaved by caspase-1 [20,21]. Ac-
DEVD-MCA cleaving activity was clearly elevated and sus-
tained with hypoxia treatment. Maximal Ac-DEVD-MCA
cleaving activity was detected 36 h after the hypoxia chal-
lenge. In contrast, SK-N-MC cells challenged with hypoxia
showed only a low level of Ac-YVAD-MCA cleaving activity
at any of the times examined in this study (Fig. 2).
Caspase-2 and -3 are synthesized as precursor molecules,
and are approximately 48 kDa and 32 kDa in size, respec-
tively. During processing, caspase-2 and -3 are proteolytically
cleaved to produce a mature enzyme composed of 18- plus 12-
kDa and 20- plus 10-kDa subunits, respectively. First, to in-
vestigate whether or not hypoxia activates caspase-3, Western
blot analysis was performed using anti-caspase-3 antibody,
which can detect the proform and active 20- or 17-kDa frag-
ment of caspase-3. In lysates prepared from control cells, a
band at 32 kDa corresponding to the full-length form of cas-
pase-3 protein was evident. As shown in Fig. 3A, hypoxia
induced the processing of caspase-3. Furthermore, new bands
corresponding to p20 and p17 of caspase-3 were detected at 36
h after hypoxic challenge in samples in which processing of
pro-caspase-3 was evident. We investigated the cleavage of
PARP by treatment with hypoxia in SK-N-MC cells. PARP
is believed to be an endogenous substrate for caspases (cas-
pase-3, -6, -7, -8, and -9). To ascertain whether apoptosis
induced by hypoxia in SK-N-MC cells is accompanied by
the activation of caspases, we examined the cleavage of
PARP. As shown in Fig. 3C, treatment with hypoxia resulted
in PARP cleavage, yielding an 85-kDa fragment typical of
caspase activity, in a time-dependent manner. The 85-kDa
PARP fragment, which is indicative of proteolytic holoen-
zyme digestion, is visible after an 18-h incubation period
with hypoxia. Furthermore, the full-length form of PARP
disappeared after a 36-h exposure to hypoxia. PARP cleavage
activity coincided with the appearance of DNA fragmentation
(Fig. 1B). Next, we examined caspase-2 using anti-C-terminal
caspase-2 antibody, which recognizes the full-length form and
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Fig. 3. Decrease in pro-forms of caspase-2 and -3, and PARP in re-
sponse to hypoxia in SK-N-MC cells. The cells were incubated for
various periods in hypoxic environment. Total cell lysates were pre-
pared and then subjected to Western blot analysis using speci¢c
antibodies for caspase-2 (C-20, Santa Cruz), caspase-3 (PharMin-
gen), and PARP (C-2-10, Clontech). Kinetic analyses of the levels
of (A) caspase-3, (B) caspase-2, and (C) PARP are shown.
Fig. 2. Hypoxia stimulated caspase activation in SK-N-MC cells.
Time course for the activation of Ac-DEVD-MCA cleaving activity
in the cell extracts after hypoxia challenge. Activation of Ac-
DEVD-MCA (b), but not Ac-YVAD-MCA (a), was observed after
hypoxia treatment. Data are the mean of triplicate reactions run in
parallel and are expressed as units of £uorescence charge per mg
protein, as described in Section 2.
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active p12 subunit of caspase-2 [22,23]. Immunoblot analysis
revealed that reduction of the band corresponding to the cas-
pase-2 pro-form occurred as early as 12 h. However, a band at
approximately p12, corresponding to the carboxyl-terminal
portion of caspase-2, was only easily detected in cell lysates
after a 36-h exposure to hypoxia (Fig. 3B). The absence of
easily detectable active fragments of caspase-3 and -2 in im-
munoblots may be because these active bands only react
weakly with the caspase-3 and -2 antibodies used in this study.
3.3. Cytochrome c released from the mitochondria during
hypoxia-induced apoptosis
The amounts of cytochrome c in the membrane and cytosol
fractions were then measured by Western blot analysis. With-
out hypoxia challenge, most of the detectable cytochrome c
was found in the membrane fraction (data not shown). The
amount of cytochrome c in the cytosol fraction increased sig-
ni¢cantly after an 18-h challenge with hypoxia, and the level
continued to increase for up to 48 h. The amounts of cyto-
chrome c in the membrane fraction showed a corresponding
decrease in a time-dependent manner (Fig. 4).
4. Discussion
The aim of this study was to elucidate the mechanism of
hypoxia-induced cell death in human SK-N-MC neuroblasto-
ma cells. We showed by studying internucleosomal DNA frag-
mentation, chromatin condensation and LDH leakage that
exposure to hypoxia elicits apoptotic cell death. We demon-
strated that caspases (at least caspase-3 and caspase-2) are
activated by hypoxia during apoptosis. Caspase activation
and apoptosis triggered by hypoxia were inhibited by treat-
ment with a caspase inhibitor. Furthermore, hypoxia resulted
in the release of cytochrome c into the cytosol from the mi-
tochondria. These ¢ndings suggest that activation of caspases
accompanied by cytochrome c release in response to hypoxia
may be involved in apoptotic cell death in this cell line.
Hypoxic conditions induced DNA fragmentation in a time-
dependent manner in SK-N-MC cells (Fig. 1B). We examined
whether caspases, known to be death proteases, are involved
in hypoxia-induced apoptosis. Treatment with caspase inhib-
itory peptide (Z-Asp-CH2-DCB) signi¢cantly inhibited the
formation of a hypoxia-induced DNA ladder (Fig. 1B). Enzy-
matic activity of a caspase-3-like protease was de¢nitely de-
tected in the cytosol extracts using a £uorescent peptide sub-
strate (DEVD-MCA), following treatment with hypoxia (Fig.
2). This result suggests that hypoxia induces apoptotic cell
death through caspase activation. Moreover, we found that
caspase-3, -2, and PARP also degrade during the apoptotic
process induced by hypoxia, with a time course similar to that
of the DNA ladder formation. Hence, we demonstrate con-
clusively that hypoxia elicits apoptosis in neuronal cells via
caspase activation.
In contrast, we could not detect caspase-1 activity in re-
sponse to hypoxia using another £uorescent peptide substrate
(YVAD-MCA) (Fig. 2). Similar results in published reports
found that caspase-1 activity is not observed during apoptosis
accompanying treatment with etoposide [24], staurosporine
[25], or cytokine deprivation [26]. In SK-N-MC cells, the
mRNA of caspase-1 was not detected by the RT-PCR method
(data not shown). These results indicate that hypoxia may
activate a caspase-3-like protease through as yet unidenti¢ed
pathways, which di¡er from those seen when cells are chal-
lenged with anti-Fas antibody.
Caspase-2 was demonstrated to be most probably activated
by caspase-3-like activity rather than by a self-activation
mechanism. This indicates that caspase-2 is activated by an-
other member of the caspase family, a caspase-3-like protease,
when cells are induced to undergo apoptosis by staurosporine
and anti-Fas antibody [23]. There is sequential activation of
caspase-1 and caspase-3 when cells are induced to undergo
apoptosis by anti-Fas antibody. After treatment with anti-
Fas antibody, a caspase-1-like protease is activated ¢rst, fol-
lowed by activation of a caspase-3-like protease, which may
be mediated by the caspase-1-like activity, and ¢nally a cas-
pase-3-like protease activates caspase-2. It is unlikely that
caspase-1 is activated by hypoxia, because neither caspase-1
mRNA nor caspase-1 activity on a substrate peptide was de-
tected in SK-N-MC cells. We showed evidence for the ¢rst
time that procaspase-2 is cleaved in response to hypoxia.
However, there remains the interesting problem of how cas-
pase-2 is activated by hypoxia in neuronal cells.
Recently, it has been revealed that the release of apopto-
genic proteins, such as cytochrome c and apoptosis-inducing
factor (AIF), from the mitochondria to the cytosol is involved
in protease activation linked to apoptosis [27^29]. Cyto-
chrome c is an essential component of the mitochondrial res-
piratory chain and is also released from the mitochondria in
response to various stimuli that also lead to apoptosis. These
include UV irradiation, etoposide, staurosporine, actinomycin
D, H2O2, and Ara-C [30,31]. Zhivotovsky et al. [32] showed
that injected cytochrome c induces apoptosis in several di¡er-
ent types of cells. Furthermore, it has been demonstrated that
only the oxidized form of cytochrome c is able to activate
caspases [33]. More recently, it was reported that cytosolic
cytochrome c activates caspase-9, and subsequently activated
caspase-9 cleaves and activates caspase-3 [34]. In this cell line,
we examined whether cytochrome c is released into the cytosol
in response to hypoxia. Western blot analysis showed that
signi¢cant amounts of cytochrome c are released 18 h after
a challenge with hypoxia, and the amount continues to in-
crease for up to 48 h. The amount of cytochrome c in the
membrane fraction including the mitochondria showed a cor-
responding decrease in a time-dependent manner. The appear-
ance of cytosolic cytochrome c correlated with the activation
of caspase-3-like protease (DEVDase), and a decrease in the
amount of the proform of caspase-2 and -3.
In conclusion, these ¢ndings indicate that hypoxia can trig-
ger apoptosis via caspase activation in SK-N-MC neuroblas-
toma cells. Our data show that hypoxia triggered caspase
FEBS 21117 17-11-98 Cyaan Magenta Geel Zwart
Fig. 4. Induction of cytochrome c release into the cytosol by hypo-
xia. The cells were challenged with hypoxia for various periods. The
cytosol fractions were separated by SDS-polyacrylamide gel electro-
phoresis and transferred onto nitrocellulose membranes. Cytochrome
c was detected by Western blot analysis using a monoclonal anti-
body (7H8.2C12) against cytochrome c (PharMingen). These are
typical results from three independent experiments.
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activation and internucleosomal DNA fragmentation. In par-
ticular, we have demonstrated that hypoxia can stimulate the
release of cytochrome c from mitochondria. Although we
have shown that hypoxia induces apoptosis via the caspase
activation accompanying cytochrome c release, the detailed
mechanism of the hypoxia-induced caspase activation linked
to apoptosis remains a subject for further investigation.
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